Milrinone Improves Pulmonary Hemodynamics and Right Ventricular Function in Chronic Pulmonary Hypertension  Edward P Chen, Hartmuth B Bittner, R.Duane.

Slides:



Advertisements
Similar presentations
The STS National Database
Advertisements

Noninvasive Screening for Pulmonary Hypertension by Exercise Testing in Congenital Heart Disease  Jan Müller, PhD, Pinar Bambul Heck, MD, Peter Ewert,
Oral Sildenafil Reduces Pulmonary Hypertension After Cardiac Surgery
Michael Kalina, DO, Frederick Giberson, MD 
Methylene Blue for Vasoplegic Syndrome After Cardiac Operation: Early Administration Improves Survival  J. Hunter Mehaffey, MD, Lily E. Johnston, MD,
Right ventricular dysfunction after cardiac transplantation: primarily related to status of donor heart  Hartmuth B Bittner, MD, PhD, Edward P Chen, MD,
Successful Surgical Management of Invasive Aspergillosis of the Pulmonary Arteries  Giorgio Zanotti, MD, Salvatore Nicolardi, MD, Marco Morsolini, MD,
John C. Kerr, B. S. , Krishna M. Jain, M. D. , Kenneth G. Swan, M. D
Mart N. van der Plas, MS, Herre J. Reesink, MD, PhD, Carel M
Factors Affecting Systemic Oxygen Delivery After Norwood Procedure With Sano Modification  Yuji Naito, MD, Mitsuru Aoki, MD, Manabu Watanabe, MD, Nobuyuki.
Theoretic Impact of Infarct Compliance on Left Ventricular Function
The Annals of Thoracic Surgery
Molecular and functional mechanisms of right ventricular adaptation in chronic pulmonary hypertension  Edward P Chen, MD, Shahab A Akhter, MD, Hartmuth.
Right Gastroepiploic Artery Graft for Myocardial Revascularization: Prevalence of Atherosclerosis and Availability as a Conduit  Kwang Ree Cho, MD, PhD,
Myocardial function in hearts with transgenic overexpression of the G protein-coupled receptor kinase 5  Edward P Chen, MD, Hartmuth B Bittner, MD, PhD,
Aortic Valve Replacement Improves Survival in Severe Aortic Stenosis Associated With Severe Pulmonary Hypertension  Ramdas G. Pai, MD, Padmini Varadarajan,
The Annals of Thoracic Surgery
Surgical Ventricular Restoration for Advanced Congestive Heart Failure: Should Pulmonary Hypertension Be a Contraindication?  Nishant D. Patel, BA, Jason.
Jennifer K. Peterson, MS, Lazaros K. Kochilas, MD, MSCR, Kirsti G
Simple Index to Predict Likelihood of Skilled Nursing Facility Admission After Coronary Artery Bypass Grafting Among Older Patients  David C. Chang, PhD,
Public policy and the practicing physician
Samuel P. Morreau, David A. Haydock, MBChB, FRACS 
Effects of Nitric Oxide After Cardiac Transplantation in the Setting of Recipient Pulmonary Hypertension  Edward P Chen, MD, Hartmuth B Bittner, MD, PhD,
Michael Argenziano, MDa, David A
Origins of the Cardiothoracic Surgery Network (CTSNet)
Impact of Age and Duration of Banding on Left Ventricular Preparation Before Anatomic Repair for Congenitally Corrected Transposition of the Great Arteries 
Who Do You Say You Are? The Annals of Thoracic Surgery
Pulmonary Arterial Wall Stiffness and Its Impact on Right Ventricular Afterload in Patients With Repaired Tetralogy of Fallot  Ryo Inuzuka, MD, PhD, Mitsuru.
Dominique Shum-Tim, MD, Brian W
Nitric Oxide and Milrinone: Combined Effect on Pulmonary Circulation After Fontan-Type Procedure: A Prospective, Randomized Study  Jiming Cai, MD, Zhaokang.
Heparin Reduces Overcirculation-Induced Pulmonary Artery Remodeling Through P38 MAPK in Piglet  Gaofeng Zhao, MD, PhD, Jingjing Seng, MD, PhD, John Beagle,
John S. Ikonomidis, MD, PhD, Ebony J
Inhaled nitric oxide, right ventricular efficiency, and pulmonary vascular mechanics: Selective vasodilation of small pulmonary vessels during hypoxic.
Physiologic Effects Of Extracellular Superoxide Dismutase Transgene Overexpression On Myocardial Function After Ischemia And Reperfusion Injury  Edward.
Anomalous Origin of Left Pulmonary Artery From Left Subclavian Artery
Coronary Artery Fistulae Involving Both Right and Left Coronary Arteries  Ahmet Bolukcu, MD, Ahmet Can Topcu, MD, Yavuz Sensoz, MD, Ilyas Kayacioglu, MD 
Frederik H. W. Jonker, MD, Hence J. M
Percutaneous Transcatheter Closure of the Aortic Valve
Pulmonary Resection for Lung Cancer in Octogenarians
Gerald G.R. Sng, Cameron D. Wright, MD  The Annals of Thoracic Surgery 
Ivo R. Henkens, MD, Alexander van Straten, MD, Martin J
Editorial Board, January 2010
Balloon Valvuloplasty Through the Right Ventricle: Another Treatment of Pulmonary Atresia With Intact Ventricular Septum  Qian-zhen Li, MD, Hua Cao, MD,
Marcus T. R. Roofthooft, MD, Klasina A. Bergman, MD, Tjalling W
Shankha S Biswas, Edward P Chen, Hartmuth B Bittner, R
An Unusual Cause of Hemoptysis in a Young Woman
Angiographic Embolization of a Traumatic Pulmonary Pseudoaneurysm
Acute Hemodynamic Benefit of Left Ventricular Apex Pacing in Children
Nitric Oxide Dose Response During Moderate and Severe Hypoxia in Swine
Off-Pump Plication of Left Ventricular Aneurysm
Begum Akay, MD, Junewai L. Reoma, MD, Daniele Camboni, MD, Joshua R
Tracheal Reconstruction in the Pediatric Population: How I Teach It
A New Minimally Invasive Technique to Occlude Ventricular Septal Defect Using an Occluder Device  Feng Li, MD, Ming Chen, MD, ZhaoKun Qiu, MD, Jing Lu,
Blaine Nease, Patricia Conant, Aubyn Marath, Peter P McKeown 
Invited Commentary The Annals of Thoracic Surgery
Edward P Chen, Hartmuth B Bittner, Damian M Craig, R
A Target for Perioperative Blood Pressure During Cardiac Operations
Pulmonary Embolectomy for Acute Massive Pulmonary Embolism
Do Patients With Complete Transposition of the Great Arteries and Severe Pulmonary Hypertension Benefit From an Arterial Switch Operation?  Hongguang.
“Transitions” for Cardiothoracic Surgeons Now Listed on the Web:
Inhaled iloprost in patients with chronic thromboembolic pulmonary hypertension: effects before and after pulmonary thromboendarterectomy  Thorsten Kramm,
Rebound Pulmonary Hypertension After Inhalation of Nitric Oxide
Endothelial Cell Injury in Cardiovascular Surgery
The endothelin antagonist BQ123 reduces pulmonary vascular resistance after surgical intervention for congenital heart disease  Ingram Schulze-Neick,
Beneficial Hemodynamic and Clinical Effects of Surgical Ventricular Restoration in Patients With Ischemic Dilated Cardiomyopathy  Sven A.F. Tulner, MD,
Justin P. V. Zachariah, MD, Frank A. Pigula, MD, John E
The Impact of New Technology on Cardiothoracic Surgical Practice
Edward Y. Chan, MD, Michael J. Reardon, MD 
Harvey Edward Garrett, MD, Bradley A. Wolf, MD 
Factors in the Selection and Management of Chest Tubes After Pulmonary Lobectomy: Results of a National Survey of Thoracic Surgeons  Samuel S. Kim, MD,
Presentation transcript:

Milrinone Improves Pulmonary Hemodynamics and Right Ventricular Function in Chronic Pulmonary Hypertension  Edward P Chen, Hartmuth B Bittner, R.Duane Davis, Peter Van Trigt  The Annals of Thoracic Surgery  Volume 63, Issue 3, Pages 814-821 (March 1997) DOI: 10.1016/S0003-4975(97)00011-8 Copyright © 1997 The Society of Thoracic Surgeons Terms and Conditions

Fig. 1 Effects of intravenous milrinone on mean pulmonary artery pressure (mPAP) in the setting of monocrotaline pyrrole–induced chronic pulmonary hypertension. Six weeks after monocrotaline pyrrole injection, slight decreases in the mean pulmonary artery pressure were observed after milrinone administration at both 0.5 and 1.0 μg · kg−1 · min−1 compared with 0 μg · kg−1 · min−1, which were not statistically significant. The Annals of Thoracic Surgery 1997 63, 814-821DOI: (10.1016/S0003-4975(97)00011-8) Copyright © 1997 The Society of Thoracic Surgeons Terms and Conditions

Fig. 2 Effects of intravenous milrinone on pulmonary vascular resistance (PVR) in the setting of monocrotaline pyrrole–induced chronic pulmonary hypertension. Six weeks after monocrotaline pyrrole injection, significant decreases in the PVR were observed after milrinone administration at 0.5 and 1.0 μg · kg−1 · min−1 as compared with 0 μg · kg−1 · min−1. There was no further significant decrease in the PVR at 1.0 μg · kg−1 · min−1 as compared with 0.5 μg · kg−1 · min−1. (∗p < 0.05 versus 0 μg · kg−1 · min−1.) The Annals of Thoracic Surgery 1997 63, 814-821DOI: (10.1016/S0003-4975(97)00011-8) Copyright © 1997 The Society of Thoracic Surgeons Terms and Conditions

Fig. 3 Effects of intravenous milrinone on the pulmonary vascular impedance spectrum in the setting of monocrotaline pyrrole–induced chronic pulmonary hypertension. Six weeks after monocrotaline pyrrole injection, there was a significant decrease in the input resistance (RIN) after milrinone infusion at both 0.5 and 1.0 μg · kg−1 · min−1 as compared with 0 μg · kg−1 · min−1. However, there was no further significant decrease in the RIN at 0.5 μg · kg−1 · min−1 as compared with 1.0 μg · kg−1 · min−1. No significant differences in the characteristic impedance (Z0) occurred after milrinone infusion compared with 0 μg · kg−1 · min−1. (∗p < 0.05 versus 0 μg · kg−1 · min−1.) The Annals of Thoracic Surgery 1997 63, 814-821DOI: (10.1016/S0003-4975(97)00011-8) Copyright © 1997 The Society of Thoracic Surgeons Terms and Conditions

Fig. 4 Effects of intravenous milrinone on right ventricular myocardial performance, as measured by right ventricular preload recruitable stroke work (RV PRSW), in the setting of monocrotaline pyrrole–induced chronic pulmonary hypertension. Milrinone infusion led to significant increases in the RV PRSW at 1.0 μg · kg−1 · min−1 as compared with 0 μg · kg−1 · min−1. The RV PRSW at an infusion rate of 0.5 μg · kg−1 · min−1 was also increased compared with 0 μg · kg−1 · min−1; however, this difference did not reach statistical significance. (∗p < 0.05 versus 0 μg · kg−1 · min−1.) The Annals of Thoracic Surgery 1997 63, 814-821DOI: (10.1016/S0003-4975(97)00011-8) Copyright © 1997 The Society of Thoracic Surgeons Terms and Conditions